Ensuring Pull Incentives for Priority Antibiotics Succeed

About the Webinar

Join Duke-Margolis to discuss national and global approaches to combating rising antimicrobial resistance (AMR) through pull incentives for novel antibiotic development, including the PASTEUR Act sponsored by U.S. Senators Michael Bennet and Todd Young. 
 
Duke-Margolis Center Director Dr. Mark McClellan will moderate discussions on tailoring pull incentives for priority antibiotic development and the need for pull incentives beyond the US and UK. Discussions will highlight recent modeling describing the appropriate magnitude of pull incentives to secure novel antibiotics, as well as complimentary actions to support pull incentives for priority antibiotics and steps toward improved public health preparedness. Discussion will also focus on global leadership and actions among G7/G20 nations to incentivize novel antibiotic development and access.

Agenda and Speakers

The agenda including speakers is available for download at the top of this page under Materials.

~~

Rising antimicrobial resistance remains a top global public health threat and efforts to support novel antibiotic development and availability are more critical and timely than ever. As the ongoing pandemic centers national and global conversations around actions to prevent and combat future infectious disease threats, the time to take action against AMR is now.  
 
Duke-Margolis publishes policy research on promising approaches and recommendations to combat AMR and rising drug-resistant infections.  See our publications below to learn more about post-market incentive strategies to support the development of innovative antibiotics and the use of a subscription model in Medicare to delink US antibiotic payments.